GlassScriptPhysician profile
Jan Kulhanek
NPI 1316908775
$15,910.40
in general payments reported to CMS, 2019-2025
61 companies · $3,794 in 2025
The $3,794 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,716 · 2020: $589 · 2021: $1,002 · 2022: $3,012 · 2023: $2,541 · 2024: $2,258 · 2025: $3,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,592.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,152.04 | 2019-2025 | |
| Pfizer INC. | $1,126.93 | 2019-2025 | |
| Amgen INC. | $1,022.17 | 2019-2025 | Repatha, Repatha |
| Aop Health US, LLC | $947.62 | 2025 | Rapiblyk |
| Astrazeneca Pharmaceuticals LP | $904.04 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Merck Sharp & Dohme LLC | $749.27 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $716.70 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $702.68 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $621.76 | 2021-2025 | Impella |
| Regeneron Healthcare Solutions, INC. | $533.03 | 2019-2025 | Evkeeza |
| Esperion Therapeutics, INC. | $520.27 | 2021-2025 | Nexletol, Nexlizet |
| Cvrx, INC. | $488.19 | 2022-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $481.90 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $474.64 | 2023-2025 | Assure Wcd |
| Abbott Laboratories | $467.90 | 2019-2023 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $425.87 | 2019-2025 | Jardiance |
| Medtronic, INC. | $378.45 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Mycarelink |
| Boston Scientific Corporation | $363.95 | 2019-2025 | Wavewriter Alpha Prime 16, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.13 | 2019-2024 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $337.07 | 2019-2023 | Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $248.45 | 2021-2023 | Arcalyst |
| Irhythm Technologies, INC. | $243.18 | 2020-2024 | Zio Monitor, Zio Xt Patch |
| Kowa Pharmaceuticals America, INC. | $203.90 | 2019-2021 | |
| Medtronic Vascular, INC. | $192.19 | 2019 | |
| Amarin Pharma, INC. | $184.11 | 2019-2022 | |
| Novo Nordisk INC | $183.19 | 2023-2024 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $182.05 | 2019 | |
| Stryker Corporation | $147.83 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $144.34 | 2019-2025 | |
| Bardy Diagnostics, INC. | $137.00 | 2022 | |
| Biosense Webster, INC. | $135.05 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $123.17 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $118.24 | 2022-2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $92.49 | 2025 | Amvuttra |
| Chiesi USA, INC. | $89.30 | 2022-2024 | Kengreal |
| Gilead Sciences, INC. | $78.91 | 2019 | |
| Lundbeck LLC | $72.04 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $71.68 | 2023-2024 | Inpefa |
| Baxter Healthcare | $45.22 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Daiichi Sankyo INC. | $39.30 | 2022-2023 | Injectafer |
| Lilly USA, LLC | $38.65 | 2022-2025 | Mounjaro, Zepbound |
| Cleerly, INC. | $27.13 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Convatec INC. | $25.69 | 2025 | |
| Biotronik INC. | $24.45 | 2022 | |
| Braemar Manufacturing, LLC | $24.22 | 2019 | |
| Philips North America LLC | $23.65 | 2024 | (Ck4) Mcot |
| Edwards Lifesciences Corporation | $21.21 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $20.95 | 2022 | |
| Microtransponder, INC. | $20.70 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.63 | 2022 | |
| Inspire Medical Systems, INC. | $18.23 | 2025 | Inspire |
| Celgene Corporation | $18.17 | 2023 | Camzyos |
| Glaxosmithkline, LLC. | $17.83 | 2025 | Arexvy |
| W. L. Gore & Associates, INC. | $17.82 | 2020 | |
| Angiodynamics, INC. | $17.72 | 2021 | |
| Trevena, INC. | $15.66 | 2022 | |
| Amryt Pharma Holdings LTD | $15.28 | 2022 | |
| Lantheus Medical Imaging, INC. | $14.48 | 2019 | |
| Itamar Medical INC | $14.06 | 2022 | |
| Tactile Systems Technology INC | $12.65 | 2019 | |
| Allergan, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Kulhanek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.